Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31792459.
- Also identified by DOI 10.1038/s41591-019-0666-1.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
How obesity and elevated androgen levels in women with polycystic ovary syndrome (PCOS) affect their offspring is unclear. In a Swedish nationwide register-based cohort and a clinical case-control study from Chile, we found that daughters of mothers with PCOS were more likely to be diagnosed with PCOS. Furthermore, female mice (F<sub>0</sub>) with PCOS-like traits induced by late-gestation injection of dihydrotestosterone, with and without obesity, produced female F<sub>1</sub>-F<sub>3</sub> offspring with PCOS-like reproductive and metabolic phenotypes. Sequencing of single metaphase II oocytes from F<sub>1</sub>-F<sub>3</sub> offspring revealed common and unique altered gene expression across all generations. Notably, four genes were also differentially expressed in serum samples from daughters in the case-control study and unrelated women with PCOS. Our findings provide evidence of transgenerational effects in female offspring of mothers with PCOS and identify possible candidate genes for the prediction of a PCOS phenotype in future generations.
Medical subject headings
- Androgens
- Pregnancy in Obesity
- Oocytes
- Polycystic Ovary Syndrome
- Prenatal Exposure Delayed Effects